ストックスクリーナーアプリを入手
3.05
0.33%
-0.01
アフターアワーズ：
3.00
-0.05
-1.64%
前日終値:
$3.06
開ける：
$3.06
24時間の取引高:
1.40M
Relative Volume:
0.92
時価総額：
$1.03B
収益：
$787.89M
当期純損益:
$20.56M
株価収益率:
52.14
EPS:
0.0585
ネットキャッシュフロー:
$96.54M
1週間 パフォーマンス:
+13.38%
1か月 パフォーマンス:
+3.39%
6か月 パフォーマンス:
+10.91%
1年 パフォーマンス:
-39.66%
1日の値動き範囲:
$2.93
$3.1299
1週間の範囲:
$2.64
$3.14
52週間の値動き範囲:
$1.77
$5.8099
Goodrx Holdings Inc Stock (GDRX) Company Profile
名前
Goodrx Holdings Inc
セクター
電話
(855) 268-2822
住所
2701 OLYMPIC BOULEVARD, SANTA MONICA
Compare GDRX vs VEEV, BTSG, TEM, HQY, HNGE
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
3.05 | 975.39M | 787.89M | 20.56M | 96.54M | 0.0585 |
VEEV
Veeva Systems Inc
|
192.74 | 28.83B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
69.03 | 13.69B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
60.27 | 10.40B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
95.31 | 7.55B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
84.05 | 6.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-27 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2026-01-22 | ダウングレード | Jefferies | Buy → Hold |
| 2025-12-09 | 開始されました | Barclays | Underweight |
| 2025-08-11 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2024-12-04 | 開始されました | Mizuho | Neutral |
| 2024-08-09 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | アップグレード | JP Morgan | Neutral → Overweight |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-01-02 | ダウングレード | BofA Securities | Buy → Underperform |
| 2023-08-10 | アップグレード | DA Davidson | Neutral → Buy |
| 2023-07-31 | アップグレード | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | 開始されました | Citigroup | Buy |
| 2022-11-04 | アップグレード | JP Morgan | Underweight → Neutral |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-08-12 | 開始されました | DA Davidson | Neutral |
| 2022-06-10 | ダウングレード | Goldman | Buy → Neutral |
| 2022-06-06 | 再開されました | BofA Securities | Buy |
| 2022-06-01 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-05-10 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | 開始されました | Wells Fargo | Equal Weight |
| 2022-04-07 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Neutral |
| 2022-03-15 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | 繰り返されました | Barclays | Overweight |
| 2022-03-01 | 繰り返されました | BofA Securities | Neutral |
| 2022-03-01 | ダウングレード | Cowen | Outperform → Market Perform |
| 2022-03-01 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | 繰り返されました | Evercore ISI | Outperform |
| 2022-03-01 | 繰り返されました | Goldman | Buy |
| 2022-03-01 | 繰り返されました | JP Morgan | Underweight |
| 2022-03-01 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2022-03-01 | 繰り返されました | SVB Leerink | Outperform |
| 2022-01-07 | 開始されました | Goldman | Buy |
| 2021-12-21 | 開始されました | Stephens | Overweight |
| 2021-12-02 | 開始されました | Jefferies | Buy |
| 2021-08-31 | アップグレード | Barclays | Equal Weight → Overweight |
| 2021-08-13 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | 開始されました | Robert W. Baird | Neutral |
| 2021-04-06 | 再開されました | Evercore ISI | Outperform |
| 2021-01-25 | 開始されました | Guggenheim | Buy |
| 2020-11-19 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | 開始されました | Barclays | Equal Weight |
| 2020-10-19 | 開始されました | BofA Securities | Neutral |
| 2020-10-19 | 開始されました | Citigroup | Buy |
| 2020-10-19 | 開始されました | Cowen | Outperform |
| 2020-10-19 | 開始されました | Credit Suisse | Outperform |
| 2020-10-19 | 開始されました | Deutsche Bank | Hold |
| 2020-10-19 | 開始されました | Goldman | Neutral |
| 2020-10-19 | 開始されました | JP Morgan | Neutral |
| 2020-10-19 | 開始されました | Morgan Stanley | Overweight |
| 2020-10-19 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | 開始されました | SVB Leerink | Outperform |
| 2020-10-19 | 開始されました | UBS | Buy |
すべてを表示
Goodrx Holdings Inc (GDRX) 最新ニュース
GDRXGoodRx Holdings Inc Options - Finviz
Enterprise value to revenue forward of GoodRx Holdings, Inc. – NASDAQ:GDRX - TradingView
GoodRx Holdings Inc (GDRX) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Enterprise value to revenue forward of GoodRx Holdings, Inc. – BOATS:GDRX - TradingView
Price to sales forward of GoodRx Holdings, Inc. – NASDAQ:GDRX - TradingView
Price to sales forward of GoodRx Holdings, Inc. – BOATS:GDRX - TradingView
GoodRx Holdings, Inc. Class A Actuals & Estimates (NASDAQ:GDRX) - TradingView
Enterprise value to EBITDA forward of GoodRx Holdings, Inc. – BOATS:GDRX - TradingView
GDRX Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of GoodRx Holdings, Inc. – BOATS:GDRX - TradingView
Enterprise value to EBIT forward of GoodRx Holdings, Inc. – NASDAQ:GDRX - TradingView
Price to earnings forward of GoodRx Holdings, Inc. – NASDAQ:GDRX - TradingView
Enterprise value to EBIT forward of GoodRx Holdings, Inc. – BOATS:GDRX - TradingView
Price to earnings forward of GoodRx Holdings, Inc. – BOATS:GDRX - TradingView
Is It Time To Consider Buying GoodRx Holdings, Inc. (NASDAQ:GDRX)? - Moomoo
GoodRx (GDRX) Q3 2024 earnings summary - Quartr
GoodRx (GDRX) Q1 earnings: Taking a look at key metrics versus estimates - MSN
GoodRx Holdings elects directors and ratifies auditor at annual meeting By Investing.com - Investing.com UK
GoodRx Holdings elects directors and ratifies auditor at annual meeting - Investing.com UK
GoodRx (NASDAQ: GDRX) investors re-elect board and ratify KPMG, back pay - Stock Titan
GoodRx (GDRX) director Trevor Bezdek granted 73,434 RSUs and updates holdings - Stock Titan
GoodRx (GDRX) director Scott Wagner receives 73,434 RSUs as equity award - Stock Titan
Q1 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks - Yahoo Finance
GoodRx Holdings Inc (GDRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GoodRx Holdings Inc (GDRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GoodRx Holdings Inc (GDRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GDRX: All proposals passed, with directors elected and no shareholder questions submitted - TradingView
GoodRx Holdings Inc (GDRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GoodRx Holdings Inc (GDRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
GoodRx Holdings Inc (GDRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
GoodRx Holdings Inc (GDRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
GoodRx Holdings Inc (GDRX) Institutional Confidence - TradingKey
GoodRx Holdings Inc (GDRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
GoodRx (GDRX) Chief Accounting Officer exercises RSUs, shares withheld for taxes - Stock Titan
GoodRx Holdings, Inc. (GDRX) Q1 earnings match estimates - MSN
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), MBX Biosciences, Inc. (MBX) and GoodRx Holdings (GDRX) - The Globe and Mail
Trevor Bezdek (GDRX) receives 110K RSUs vesting in 2027 - Stock Titan
GoodRx Holdings Expands Recurring Revenue Streams Through Companion Pet Prescription PlatformMargin Expansion Trends - dars.gov.et
GoodRx Leverages Companion Offering to Bolster Recurring Revenue StreamsQuarterly Earnings Report - newsline.com
GoodRx Holdings Strengthens Recurring Revenue Base with Companion Product ExpansionManagement Tone Analysis - newsline.com
GoodRx Launches Companion to Strengthen Recurring Revenue StreamsMargin Compression Risk - newsline.com
GoodRx Boosts Recurring Revenue with Companion Subscription OfferingEarnings Whisper Number - newsline.com
GoodRx Holdings, Inc. (GDRX) Strengthens Recurring Revenue Base with Companion - Insider Monkey
GoodRx Enhances Subscription Model with Companion Offering to Bolster Recurring Revenue - dars.gov.et
3 Penny Stocks With Market Caps Over $100M To Watch - simplywall.st
GoodRx (NASDAQ: GDRX) director grant adds 4,642 deferred stock units - Stock Titan
GoodRx (NASDAQ: GDRX) director receives 4,642 deferred stock units - Stock Titan
How The Shifting Story For GoodRx (GDRX) Is Reshaping Analyst Views And Valuation - Yahoo Finance
GoodRx launches $14.99 monthly healthcare subscription service - Investing.com UK
GoodRx (GDRX) Introduces New Monthly Subscription Service - GuruFocus
GoodRx (GDRX) Launches Subscription Plan for Affordable Healthca - GuruFocus
Goodrx Holdings Inc (GDRX) 財務データ
収益
当期純利益
現金流量
EPS
Goodrx Holdings Inc (GDRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| REY-GIRAUD AGNES | Director |
Mar 12 '26 |
Option Exercise |
0.47 |
192,185 |
90,327 |
277,633 |
| Spectrum Equity VII, L.P. | 10% Owner |
Oct 15 '25 |
Sale |
4.00 |
23,771 |
95,103 |
0 |
1.79%
0.10%
大文字化:
|
ボリューム (24 時間):